JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1093012, encodeId=b6ad1093012d6, content=文章投稿应该按照什么思路开始？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008104, encodeId=6a68100810481, content=中了第二篇，但不建议多投，中科院3区，意义不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Aug 15 17:42:00 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918252, encodeId=e7a59182529c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：还是蛮容易接收的，建议也不是很多，很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqtuCfegC3ryJHcic2UBPKrctdEHriaDp39JFNAycZ2KiaL7LGlY5p0MYV5WamZGkoruC5VzyWSticGjA/132, createdBy=3d2c2194719, createdName=1209f8e0m50(暂无昵称), createdTime=Wed Jan 20 07:20:03 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833041, encodeId=544b83304127, content=审稿速度:4.0 经验分享：一个月让大修，两个月后通知accept，再两个月后online, 在两个月正式出版。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f35414062, createdName=ms4354791198256231, createdTime=Sat Aug 13 17:11:34 CST 2016, time=2016-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920059, encodeId=499a92005934, content=2021.1.11投稿，2021.1.26还在new submission的under review状态，感觉稍慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/c408d3ef2b4e4285afccf7d39ec1f273/aaaf9fdaecca4973925f279e701f8ab6.jpg, createdBy=99205232199, createdName=SALAZAR, createdTime=Tue Jan 26 17:44:53 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539596, encodeId=084d53959633, content=一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chengqi2017, createdTime=Tue Jul 18 18:31:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565094, encodeId=6c00565094ac, content=你好请问从投稿到接收用了多久啊spanclassquotejessicaq20110820发表br研究方向内分泌接收率约75审稿时间约3个月命中率还好就是发表太慢接受都已经4个月了还在AwaitingProductionChecklist还没有在线发表唉span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bd22486428, createdName=1246c615m71(暂无昵称), createdTime=Thu Jan 03 10:26:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565093, encodeId=cca2565093c5, content=你好请问从投稿到接收多长时间啊spanclassquotealbertang20130622发表br研究方向diabeticcomplicationsriskfactoranalysis接收率约75审稿时间约3个月还好临床的容易发span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bd22486428, createdName=1246c615m71(暂无昵称), createdTime=Thu Jan 03 10:25:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559406, encodeId=6e79559406b5, content=怎么打不开主页137****9394(暂无匿称) 2016-10-01 13:29:00 发表: 请问需要版面费吗, beContent=137****9394(暂无匿称) 2016-10-01 13:29:00 发表: 请问需要版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9a91979635, createdName=eagle0094, createdTime=Fri Jul 20 00:00:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527812, encodeId=50eb52e81266, content=请问需要版面费吗albertang 2013-06-22 发表:: 研究方向：diabetic complications;risk factor analysis; 接收率：约75% 审稿时间：约3个月还好, 临床的容易发..., beContent=albertang 2013-06-22 发表:: 研究方向：diabetic complications;risk factor analysis; 接收率：约75% 审稿时间：约3个月还好, 临床的容易发..., objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef6f1960121, createdName=1e133a0am94(暂无匿称), createdTime=Sat Oct 01 13:29:00 CST 2016, time=2016-10-01, status=1, ipAttribution=)]

2021-12-27 msSSSSSD

文章投稿应该按照什么思路开始？

64 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1093012, encodeId=b6ad1093012d6, content=文章投稿应该按照什么思路开始？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008104, encodeId=6a68100810481, content=中了第二篇，但不建议多投，中科院3区，意义不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Aug 15 17:42:00 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918252, encodeId=e7a59182529c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：还是蛮容易接收的，建议也不是很多，很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqtuCfegC3ryJHcic2UBPKrctdEHriaDp39JFNAycZ2KiaL7LGlY5p0MYV5WamZGkoruC5VzyWSticGjA/132, createdBy=3d2c2194719, createdName=1209f8e0m50(暂无昵称), createdTime=Wed Jan 20 07:20:03 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833041, encodeId=544b83304127, content=审稿速度:4.0 经验分享：一个月让大修，两个月后通知accept，再两个月后online, 在两个月正式出版。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f35414062, createdName=ms4354791198256231, createdTime=Sat Aug 13 17:11:34 CST 2016, time=2016-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920059, encodeId=499a92005934, content=2021.1.11投稿，2021.1.26还在new submission的under review状态，感觉稍慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/c408d3ef2b4e4285afccf7d39ec1f273/aaaf9fdaecca4973925f279e701f8ab6.jpg, createdBy=99205232199, createdName=SALAZAR, createdTime=Tue Jan 26 17:44:53 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539596, encodeId=084d53959633, content=一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chengqi2017, createdTime=Tue Jul 18 18:31:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565094, encodeId=6c00565094ac, content=你好请问从投稿到接收用了多久啊spanclassquotejessicaq20110820发表br研究方向内分泌接收率约75审稿时间约3个月命中率还好就是发表太慢接受都已经4个月了还在AwaitingProductionChecklist还没有在线发表唉span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bd22486428, createdName=1246c615m71(暂无昵称), createdTime=Thu Jan 03 10:26:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565093, encodeId=cca2565093c5, content=你好请问从投稿到接收多长时间啊spanclassquotealbertang20130622发表br研究方向diabeticcomplicationsriskfactoranalysis接收率约75审稿时间约3个月还好临床的容易发span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bd22486428, createdName=1246c615m71(暂无昵称), createdTime=Thu Jan 03 10:25:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559406, encodeId=6e79559406b5, content=怎么打不开主页137****9394(暂无匿称) 2016-10-01 13:29:00 发表: 请问需要版面费吗, beContent=137****9394(暂无匿称) 2016-10-01 13:29:00 发表: 请问需要版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9a91979635, createdName=eagle0094, createdTime=Fri Jul 20 00:00:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527812, encodeId=50eb52e81266, content=请问需要版面费吗albertang 2013-06-22 发表:: 研究方向：diabetic complications;risk factor analysis; 接收率：约75% 审稿时间：约3个月还好, 临床的容易发..., beContent=albertang 2013-06-22 发表:: 研究方向：diabetic complications;risk factor analysis; 接收率：约75% 审稿时间：约3个月还好, 临床的容易发..., objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef6f1960121, createdName=1e133a0am94(暂无匿称), createdTime=Sat Oct 01 13:29:00 CST 2016, time=2016-10-01, status=1, ipAttribution=)]

2021-08-15 1465389cm38暂无昵称

中了第二篇，但不建议多投，中科院3区，意义不大

79 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1093012, encodeId=b6ad1093012d6, content=文章投稿应该按照什么思路开始？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008104, encodeId=6a68100810481, content=中了第二篇，但不建议多投，中科院3区，意义不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Aug 15 17:42:00 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918252, encodeId=e7a59182529c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：还是蛮容易接收的，建议也不是很多，很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqtuCfegC3ryJHcic2UBPKrctdEHriaDp39JFNAycZ2KiaL7LGlY5p0MYV5WamZGkoruC5VzyWSticGjA/132, createdBy=3d2c2194719, createdName=1209f8e0m50(暂无昵称), createdTime=Wed Jan 20 07:20:03 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833041, encodeId=544b83304127, content=审稿速度:4.0 经验分享：一个月让大修，两个月后通知accept，再两个月后online, 在两个月正式出版。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f35414062, createdName=ms4354791198256231, createdTime=Sat Aug 13 17:11:34 CST 2016, time=2016-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920059, encodeId=499a92005934, content=2021.1.11投稿，2021.1.26还在new submission的under review状态，感觉稍慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/c408d3ef2b4e4285afccf7d39ec1f273/aaaf9fdaecca4973925f279e701f8ab6.jpg, createdBy=99205232199, createdName=SALAZAR, createdTime=Tue Jan 26 17:44:53 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539596, encodeId=084d53959633, content=一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chengqi2017, createdTime=Tue Jul 18 18:31:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565094, encodeId=6c00565094ac, content=你好请问从投稿到接收用了多久啊spanclassquotejessicaq20110820发表br研究方向内分泌接收率约75审稿时间约3个月命中率还好就是发表太慢接受都已经4个月了还在AwaitingProductionChecklist还没有在线发表唉span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bd22486428, createdName=1246c615m71(暂无昵称), createdTime=Thu Jan 03 10:26:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565093, encodeId=cca2565093c5, content=你好请问从投稿到接收多长时间啊spanclassquotealbertang20130622发表br研究方向diabeticcomplicationsriskfactoranalysis接收率约75审稿时间约3个月还好临床的容易发span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bd22486428, createdName=1246c615m71(暂无昵称), createdTime=Thu Jan 03 10:25:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559406, encodeId=6e79559406b5, content=怎么打不开主页137****9394(暂无匿称) 2016-10-01 13:29:00 发表: 请问需要版面费吗, beContent=137****9394(暂无匿称) 2016-10-01 13:29:00 发表: 请问需要版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9a91979635, createdName=eagle0094, createdTime=Fri Jul 20 00:00:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527812, encodeId=50eb52e81266, content=请问需要版面费吗albertang 2013-06-22 发表:: 研究方向：diabetic complications;risk factor analysis; 接收率：约75% 审稿时间：约3个月还好, 临床的容易发..., beContent=albertang 2013-06-22 发表:: 研究方向：diabetic complications;risk factor analysis; 接收率：约75% 审稿时间：约3个月还好, 临床的容易发..., objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef6f1960121, createdName=1e133a0am94(暂无匿称), createdTime=Sat Oct 01 13:29:00 CST 2016, time=2016-10-01, status=1, ipAttribution=)]

2021-01-20 1209f8e0m50(暂无昵称)

审稿速度:2.0 | 投稿命中率:75.0
经验分享：还是蛮容易接收的，建议也不是很多，很友好

239 21

展开21条回复

[GetPortalCommentsPageByObjectIdResponse(id=1093012, encodeId=b6ad1093012d6, content=文章投稿应该按照什么思路开始？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008104, encodeId=6a68100810481, content=中了第二篇，但不建议多投，中科院3区，意义不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Aug 15 17:42:00 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918252, encodeId=e7a59182529c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：还是蛮容易接收的，建议也不是很多，很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqtuCfegC3ryJHcic2UBPKrctdEHriaDp39JFNAycZ2KiaL7LGlY5p0MYV5WamZGkoruC5VzyWSticGjA/132, createdBy=3d2c2194719, createdName=1209f8e0m50(暂无昵称), createdTime=Wed Jan 20 07:20:03 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833041, encodeId=544b83304127, content=审稿速度:4.0 经验分享：一个月让大修，两个月后通知accept，再两个月后online, 在两个月正式出版。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f35414062, createdName=ms4354791198256231, createdTime=Sat Aug 13 17:11:34 CST 2016, time=2016-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920059, encodeId=499a92005934, content=2021.1.11投稿，2021.1.26还在new submission的under review状态，感觉稍慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/c408d3ef2b4e4285afccf7d39ec1f273/aaaf9fdaecca4973925f279e701f8ab6.jpg, createdBy=99205232199, createdName=SALAZAR, createdTime=Tue Jan 26 17:44:53 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539596, encodeId=084d53959633, content=一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chengqi2017, createdTime=Tue Jul 18 18:31:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565094, encodeId=6c00565094ac, content=你好请问从投稿到接收用了多久啊spanclassquotejessicaq20110820发表br研究方向内分泌接收率约75审稿时间约3个月命中率还好就是发表太慢接受都已经4个月了还在AwaitingProductionChecklist还没有在线发表唉span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bd22486428, createdName=1246c615m71(暂无昵称), createdTime=Thu Jan 03 10:26:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565093, encodeId=cca2565093c5, content=你好请问从投稿到接收多长时间啊spanclassquotealbertang20130622发表br研究方向diabeticcomplicationsriskfactoranalysis接收率约75审稿时间约3个月还好临床的容易发span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bd22486428, createdName=1246c615m71(暂无昵称), createdTime=Thu Jan 03 10:25:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559406, encodeId=6e79559406b5, content=怎么打不开主页137****9394(暂无匿称) 2016-10-01 13:29:00 发表: 请问需要版面费吗, beContent=137****9394(暂无匿称) 2016-10-01 13:29:00 发表: 请问需要版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9a91979635, createdName=eagle0094, createdTime=Fri Jul 20 00:00:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527812, encodeId=50eb52e81266, content=请问需要版面费吗albertang 2013-06-22 发表:: 研究方向：diabetic complications;risk factor analysis; 接收率：约75% 审稿时间：约3个月还好, 临床的容易发..., beContent=albertang 2013-06-22 发表:: 研究方向：diabetic complications;risk factor analysis; 接收率：约75% 审稿时间：约3个月还好, 临床的容易发..., objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef6f1960121, createdName=1e133a0am94(暂无匿称), createdTime=Sat Oct 01 13:29:00 CST 2016, time=2016-10-01, status=1, ipAttribution=)]

2016-08-13 ms4354791198256231

审稿速度:4.0
经验分享：一个月让大修，两个月后通知accept，再两个月后online, 在两个月正式出版。

141 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1093012, encodeId=b6ad1093012d6, content=文章投稿应该按照什么思路开始？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008104, encodeId=6a68100810481, content=中了第二篇，但不建议多投，中科院3区，意义不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Aug 15 17:42:00 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918252, encodeId=e7a59182529c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：还是蛮容易接收的，建议也不是很多，很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqtuCfegC3ryJHcic2UBPKrctdEHriaDp39JFNAycZ2KiaL7LGlY5p0MYV5WamZGkoruC5VzyWSticGjA/132, createdBy=3d2c2194719, createdName=1209f8e0m50(暂无昵称), createdTime=Wed Jan 20 07:20:03 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833041, encodeId=544b83304127, content=审稿速度:4.0 经验分享：一个月让大修，两个月后通知accept，再两个月后online, 在两个月正式出版。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f35414062, createdName=ms4354791198256231, createdTime=Sat Aug 13 17:11:34 CST 2016, time=2016-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920059, encodeId=499a92005934, content=2021.1.11投稿，2021.1.26还在new submission的under review状态，感觉稍慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/c408d3ef2b4e4285afccf7d39ec1f273/aaaf9fdaecca4973925f279e701f8ab6.jpg, createdBy=99205232199, createdName=SALAZAR, createdTime=Tue Jan 26 17:44:53 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539596, encodeId=084d53959633, content=一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chengqi2017, createdTime=Tue Jul 18 18:31:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565094, encodeId=6c00565094ac, content=你好请问从投稿到接收用了多久啊spanclassquotejessicaq20110820发表br研究方向内分泌接收率约75审稿时间约3个月命中率还好就是发表太慢接受都已经4个月了还在AwaitingProductionChecklist还没有在线发表唉span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bd22486428, createdName=1246c615m71(暂无昵称), createdTime=Thu Jan 03 10:26:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565093, encodeId=cca2565093c5, content=你好请问从投稿到接收多长时间啊spanclassquotealbertang20130622发表br研究方向diabeticcomplicationsriskfactoranalysis接收率约75审稿时间约3个月还好临床的容易发span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bd22486428, createdName=1246c615m71(暂无昵称), createdTime=Thu Jan 03 10:25:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559406, encodeId=6e79559406b5, content=怎么打不开主页137****9394(暂无匿称) 2016-10-01 13:29:00 发表: 请问需要版面费吗, beContent=137****9394(暂无匿称) 2016-10-01 13:29:00 发表: 请问需要版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9a91979635, createdName=eagle0094, createdTime=Fri Jul 20 00:00:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527812, encodeId=50eb52e81266, content=请问需要版面费吗albertang 2013-06-22 发表:: 研究方向：diabetic complications;risk factor analysis; 接收率：约75% 审稿时间：约3个月还好, 临床的容易发..., beContent=albertang 2013-06-22 发表:: 研究方向：diabetic complications;risk factor analysis; 接收率：约75% 审稿时间：约3个月还好, 临床的容易发..., objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef6f1960121, createdName=1e133a0am94(暂无匿称), createdTime=Sat Oct 01 13:29:00 CST 2016, time=2016-10-01, status=1, ipAttribution=)]

2021-01-26 SALAZAR

2021.1.11投稿，2021.1.26还在new submission的under review状态，感觉稍慢

128 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1093012, encodeId=b6ad1093012d6, content=文章投稿应该按照什么思路开始？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008104, encodeId=6a68100810481, content=中了第二篇，但不建议多投，中科院3区，意义不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Aug 15 17:42:00 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918252, encodeId=e7a59182529c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：还是蛮容易接收的，建议也不是很多，很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqtuCfegC3ryJHcic2UBPKrctdEHriaDp39JFNAycZ2KiaL7LGlY5p0MYV5WamZGkoruC5VzyWSticGjA/132, createdBy=3d2c2194719, createdName=1209f8e0m50(暂无昵称), createdTime=Wed Jan 20 07:20:03 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833041, encodeId=544b83304127, content=审稿速度:4.0 经验分享：一个月让大修，两个月后通知accept，再两个月后online, 在两个月正式出版。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f35414062, createdName=ms4354791198256231, createdTime=Sat Aug 13 17:11:34 CST 2016, time=2016-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920059, encodeId=499a92005934, content=2021.1.11投稿，2021.1.26还在new submission的under review状态，感觉稍慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/c408d3ef2b4e4285afccf7d39ec1f273/aaaf9fdaecca4973925f279e701f8ab6.jpg, createdBy=99205232199, createdName=SALAZAR, createdTime=Tue Jan 26 17:44:53 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539596, encodeId=084d53959633, content=一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chengqi2017, createdTime=Tue Jul 18 18:31:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565094, encodeId=6c00565094ac, content=你好请问从投稿到接收用了多久啊spanclassquotejessicaq20110820发表br研究方向内分泌接收率约75审稿时间约3个月命中率还好就是发表太慢接受都已经4个月了还在AwaitingProductionChecklist还没有在线发表唉span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bd22486428, createdName=1246c615m71(暂无昵称), createdTime=Thu Jan 03 10:26:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565093, encodeId=cca2565093c5, content=你好请问从投稿到接收多长时间啊spanclassquotealbertang20130622发表br研究方向diabeticcomplicationsriskfactoranalysis接收率约75审稿时间约3个月还好临床的容易发span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bd22486428, createdName=1246c615m71(暂无昵称), createdTime=Thu Jan 03 10:25:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559406, encodeId=6e79559406b5, content=怎么打不开主页137****9394(暂无匿称) 2016-10-01 13:29:00 发表: 请问需要版面费吗, beContent=137****9394(暂无匿称) 2016-10-01 13:29:00 发表: 请问需要版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9a91979635, createdName=eagle0094, createdTime=Fri Jul 20 00:00:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527812, encodeId=50eb52e81266, content=请问需要版面费吗albertang 2013-06-22 发表:: 研究方向：diabetic complications;risk factor analysis; 接收率：约75% 审稿时间：约3个月还好, 临床的容易发..., beContent=albertang 2013-06-22 发表:: 研究方向：diabetic complications;risk factor analysis; 接收率：约75% 审稿时间：约3个月还好, 临床的容易发..., objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef6f1960121, createdName=1e133a0am94(暂无匿称), createdTime=Sat Oct 01 13:29:00 CST 2016, time=2016-10-01, status=1, ipAttribution=)]

2017-07-18 chengqi2017

一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的

399 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1093012, encodeId=b6ad1093012d6, content=文章投稿应该按照什么思路开始？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008104, encodeId=6a68100810481, content=中了第二篇，但不建议多投，中科院3区，意义不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Aug 15 17:42:00 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918252, encodeId=e7a59182529c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：还是蛮容易接收的，建议也不是很多，很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqtuCfegC3ryJHcic2UBPKrctdEHriaDp39JFNAycZ2KiaL7LGlY5p0MYV5WamZGkoruC5VzyWSticGjA/132, createdBy=3d2c2194719, createdName=1209f8e0m50(暂无昵称), createdTime=Wed Jan 20 07:20:03 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833041, encodeId=544b83304127, content=审稿速度:4.0 经验分享：一个月让大修，两个月后通知accept，再两个月后online, 在两个月正式出版。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f35414062, createdName=ms4354791198256231, createdTime=Sat Aug 13 17:11:34 CST 2016, time=2016-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920059, encodeId=499a92005934, content=2021.1.11投稿，2021.1.26还在new submission的under review状态，感觉稍慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/c408d3ef2b4e4285afccf7d39ec1f273/aaaf9fdaecca4973925f279e701f8ab6.jpg, createdBy=99205232199, createdName=SALAZAR, createdTime=Tue Jan 26 17:44:53 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539596, encodeId=084d53959633, content=一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chengqi2017, createdTime=Tue Jul 18 18:31:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565094, encodeId=6c00565094ac, content=你好请问从投稿到接收用了多久啊spanclassquotejessicaq20110820发表br研究方向内分泌接收率约75审稿时间约3个月命中率还好就是发表太慢接受都已经4个月了还在AwaitingProductionChecklist还没有在线发表唉span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bd22486428, createdName=1246c615m71(暂无昵称), createdTime=Thu Jan 03 10:26:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565093, encodeId=cca2565093c5, content=你好请问从投稿到接收多长时间啊spanclassquotealbertang20130622发表br研究方向diabeticcomplicationsriskfactoranalysis接收率约75审稿时间约3个月还好临床的容易发span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bd22486428, createdName=1246c615m71(暂无昵称), createdTime=Thu Jan 03 10:25:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559406, encodeId=6e79559406b5, content=怎么打不开主页137****9394(暂无匿称) 2016-10-01 13:29:00 发表: 请问需要版面费吗, beContent=137****9394(暂无匿称) 2016-10-01 13:29:00 发表: 请问需要版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9a91979635, createdName=eagle0094, createdTime=Fri Jul 20 00:00:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527812, encodeId=50eb52e81266, content=请问需要版面费吗albertang 2013-06-22 发表:: 研究方向：diabetic complications;risk factor analysis; 接收率：约75% 审稿时间：约3个月还好, 临床的容易发..., beContent=albertang 2013-06-22 发表:: 研究方向：diabetic complications;risk factor analysis; 接收率：约75% 审稿时间：约3个月还好, 临床的容易发..., objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef6f1960121, createdName=1e133a0am94(暂无匿称), createdTime=Sat Oct 01 13:29:00 CST 2016, time=2016-10-01, status=1, ipAttribution=)]

2019-01-03 1246c615m71(暂无昵称)

你好请问从投稿到接收用了多久啊spanclassquotejessicaq20110820发表br研究方向内分泌接收率约75审稿时间约3个月命中率还好就是发表太慢接受都已经4个月了还在AwaitingProductionChecklist还没有在线发表唉span

206 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1093012, encodeId=b6ad1093012d6, content=文章投稿应该按照什么思路开始？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008104, encodeId=6a68100810481, content=中了第二篇，但不建议多投，中科院3区，意义不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Aug 15 17:42:00 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918252, encodeId=e7a59182529c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：还是蛮容易接收的，建议也不是很多，很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqtuCfegC3ryJHcic2UBPKrctdEHriaDp39JFNAycZ2KiaL7LGlY5p0MYV5WamZGkoruC5VzyWSticGjA/132, createdBy=3d2c2194719, createdName=1209f8e0m50(暂无昵称), createdTime=Wed Jan 20 07:20:03 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833041, encodeId=544b83304127, content=审稿速度:4.0 经验分享：一个月让大修，两个月后通知accept，再两个月后online, 在两个月正式出版。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f35414062, createdName=ms4354791198256231, createdTime=Sat Aug 13 17:11:34 CST 2016, time=2016-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920059, encodeId=499a92005934, content=2021.1.11投稿，2021.1.26还在new submission的under review状态，感觉稍慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/c408d3ef2b4e4285afccf7d39ec1f273/aaaf9fdaecca4973925f279e701f8ab6.jpg, createdBy=99205232199, createdName=SALAZAR, createdTime=Tue Jan 26 17:44:53 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539596, encodeId=084d53959633, content=一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chengqi2017, createdTime=Tue Jul 18 18:31:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565094, encodeId=6c00565094ac, content=你好请问从投稿到接收用了多久啊spanclassquotejessicaq20110820发表br研究方向内分泌接收率约75审稿时间约3个月命中率还好就是发表太慢接受都已经4个月了还在AwaitingProductionChecklist还没有在线发表唉span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bd22486428, createdName=1246c615m71(暂无昵称), createdTime=Thu Jan 03 10:26:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565093, encodeId=cca2565093c5, content=你好请问从投稿到接收多长时间啊spanclassquotealbertang20130622发表br研究方向diabeticcomplicationsriskfactoranalysis接收率约75审稿时间约3个月还好临床的容易发span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bd22486428, createdName=1246c615m71(暂无昵称), createdTime=Thu Jan 03 10:25:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559406, encodeId=6e79559406b5, content=怎么打不开主页137****9394(暂无匿称) 2016-10-01 13:29:00 发表: 请问需要版面费吗, beContent=137****9394(暂无匿称) 2016-10-01 13:29:00 发表: 请问需要版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9a91979635, createdName=eagle0094, createdTime=Fri Jul 20 00:00:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527812, encodeId=50eb52e81266, content=请问需要版面费吗albertang 2013-06-22 发表:: 研究方向：diabetic complications;risk factor analysis; 接收率：约75% 审稿时间：约3个月还好, 临床的容易发..., beContent=albertang 2013-06-22 发表:: 研究方向：diabetic complications;risk factor analysis; 接收率：约75% 审稿时间：约3个月还好, 临床的容易发..., objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef6f1960121, createdName=1e133a0am94(暂无匿称), createdTime=Sat Oct 01 13:29:00 CST 2016, time=2016-10-01, status=1, ipAttribution=)]

2019-01-03 1246c615m71(暂无昵称)

你好请问从投稿到接收多长时间啊spanclassquotealbertang20130622发表br研究方向diabeticcomplicationsriskfactoranalysis接收率约75审稿时间约3个月还好临床的容易发span

194 0

[GetPortalCommentsPageByObjectIdResponse(id=1093012, encodeId=b6ad1093012d6, content=文章投稿应该按照什么思路开始？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008104, encodeId=6a68100810481, content=中了第二篇，但不建议多投，中科院3区，意义不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Aug 15 17:42:00 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918252, encodeId=e7a59182529c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：还是蛮容易接收的，建议也不是很多，很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqtuCfegC3ryJHcic2UBPKrctdEHriaDp39JFNAycZ2KiaL7LGlY5p0MYV5WamZGkoruC5VzyWSticGjA/132, createdBy=3d2c2194719, createdName=1209f8e0m50(暂无昵称), createdTime=Wed Jan 20 07:20:03 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833041, encodeId=544b83304127, content=审稿速度:4.0 经验分享：一个月让大修，两个月后通知accept，再两个月后online, 在两个月正式出版。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f35414062, createdName=ms4354791198256231, createdTime=Sat Aug 13 17:11:34 CST 2016, time=2016-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920059, encodeId=499a92005934, content=2021.1.11投稿，2021.1.26还在new submission的under review状态，感觉稍慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/c408d3ef2b4e4285afccf7d39ec1f273/aaaf9fdaecca4973925f279e701f8ab6.jpg, createdBy=99205232199, createdName=SALAZAR, createdTime=Tue Jan 26 17:44:53 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539596, encodeId=084d53959633, content=一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chengqi2017, createdTime=Tue Jul 18 18:31:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565094, encodeId=6c00565094ac, content=你好请问从投稿到接收用了多久啊spanclassquotejessicaq20110820发表br研究方向内分泌接收率约75审稿时间约3个月命中率还好就是发表太慢接受都已经4个月了还在AwaitingProductionChecklist还没有在线发表唉span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bd22486428, createdName=1246c615m71(暂无昵称), createdTime=Thu Jan 03 10:26:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565093, encodeId=cca2565093c5, content=你好请问从投稿到接收多长时间啊spanclassquotealbertang20130622发表br研究方向diabeticcomplicationsriskfactoranalysis接收率约75审稿时间约3个月还好临床的容易发span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bd22486428, createdName=1246c615m71(暂无昵称), createdTime=Thu Jan 03 10:25:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559406, encodeId=6e79559406b5, content=怎么打不开主页137****9394(暂无匿称) 2016-10-01 13:29:00 发表: 请问需要版面费吗, beContent=137****9394(暂无匿称) 2016-10-01 13:29:00 发表: 请问需要版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9a91979635, createdName=eagle0094, createdTime=Fri Jul 20 00:00:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527812, encodeId=50eb52e81266, content=请问需要版面费吗albertang 2013-06-22 发表:: 研究方向：diabetic complications;risk factor analysis; 接收率：约75% 审稿时间：约3个月还好, 临床的容易发..., beContent=albertang 2013-06-22 发表:: 研究方向：diabetic complications;risk factor analysis; 接收率：约75% 审稿时间：约3个月还好, 临床的容易发..., objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef6f1960121, createdName=1e133a0am94(暂无匿称), createdTime=Sat Oct 01 13:29:00 CST 2016, time=2016-10-01, status=1, ipAttribution=)]

2018-07-20 eagle0094

怎么打不开主页137****9394(暂无匿称) 2016-10-01 13:29:00 发表:
请问需要版面费吗

137****9394(暂无匿称) 2016-10-01 13:29:00 发表: 请问需要版面费吗

286 0

[GetPortalCommentsPageByObjectIdResponse(id=1093012, encodeId=b6ad1093012d6, content=文章投稿应该按照什么思路开始？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008104, encodeId=6a68100810481, content=中了第二篇，但不建议多投，中科院3区，意义不大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Aug 15 17:42:00 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918252, encodeId=e7a59182529c, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：还是蛮容易接收的，建议也不是很多，很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqtuCfegC3ryJHcic2UBPKrctdEHriaDp39JFNAycZ2KiaL7LGlY5p0MYV5WamZGkoruC5VzyWSticGjA/132, createdBy=3d2c2194719, createdName=1209f8e0m50(暂无昵称), createdTime=Wed Jan 20 07:20:03 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833041, encodeId=544b83304127, content=审稿速度:4.0 经验分享：一个月让大修，两个月后通知accept，再两个月后online, 在两个月正式出版。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f35414062, createdName=ms4354791198256231, createdTime=Sat Aug 13 17:11:34 CST 2016, time=2016-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920059, encodeId=499a92005934, content=2021.1.11投稿，2021.1.26还在new submission的under review状态，感觉稍慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/c408d3ef2b4e4285afccf7d39ec1f273/aaaf9fdaecca4973925f279e701f8ab6.jpg, createdBy=99205232199, createdName=SALAZAR, createdTime=Tue Jan 26 17:44:53 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539596, encodeId=084d53959633, content=一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chengqi2017, createdTime=Tue Jul 18 18:31:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565094, encodeId=6c00565094ac, content=你好请问从投稿到接收用了多久啊spanclassquotejessicaq20110820发表br研究方向内分泌接收率约75审稿时间约3个月命中率还好就是发表太慢接受都已经4个月了还在AwaitingProductionChecklist还没有在线发表唉span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bd22486428, createdName=1246c615m71(暂无昵称), createdTime=Thu Jan 03 10:26:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565093, encodeId=cca2565093c5, content=你好请问从投稿到接收多长时间啊spanclassquotealbertang20130622发表br研究方向diabeticcomplicationsriskfactoranalysis接收率约75审稿时间约3个月还好临床的容易发span, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bd22486428, createdName=1246c615m71(暂无昵称), createdTime=Thu Jan 03 10:25:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559406, encodeId=6e79559406b5, content=怎么打不开主页137****9394(暂无匿称) 2016-10-01 13:29:00 发表: 请问需要版面费吗, beContent=137****9394(暂无匿称) 2016-10-01 13:29:00 发表: 请问需要版面费吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9a91979635, createdName=eagle0094, createdTime=Fri Jul 20 00:00:00 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527812, encodeId=50eb52e81266, content=请问需要版面费吗albertang 2013-06-22 发表:: 研究方向：diabetic complications;risk factor analysis; 接收率：约75% 审稿时间：约3个月还好, 临床的容易发..., beContent=albertang 2013-06-22 发表:: 研究方向：diabetic complications;risk factor analysis; 接收率：约75% 审稿时间：约3个月还好, 临床的容易发..., objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef6f1960121, createdName=1e133a0am94(暂无匿称), createdTime=Sat Oct 01 13:29:00 CST 2016, time=2016-10-01, status=1, ipAttribution=)]

2016-10-01 1e133a0am94(暂无匿称)

请问需要版面费吗albertang 2013-06-22 发表::
研究方向：diabetic complications;risk factor analysis; 接收率：约75% 审稿时间：约3个月还好, 临床的容易发...

albertang 2013-06-22 发表:: 研究方向：diabetic complications;risk factor analysis; 接收率：约75% 审稿时间：约3个月还好, 临床的容易发...

334 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务